Abstract:Jinxin Ma, 1, &ast Peng Yu, 1, &ast Shang Ma, 1, &ast Jinjin Li, 1 Zhen Wang, 1 Kunpeng Hu, 1 Xinzhe Su, 1 Bei Zhang, 1 Shao Cheng, 1– 3 Shangzeng Wang 1– 3 1 School of Osteopathy, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China; 2 Department of Arthropathy, Henan Province Hospital of Chinese Medicine (The Second Affiliated Hospital of Henan University of Chinese Medicine), Zhengzhou, People's Republic of China; 3 School of Osteopathy, Henan Province Engineering Research Center of Basic and Clinical Research of Bone and Joint Repair in Chinese Medicine, Zhengzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shao Cheng; Shangzeng Wang, 156 Jinshui East Road, Zhengzhou, Henan, People's Republic of China, Tel +86 15093141825 ; +86 13838527504, Fax +0371-86667366, Email ; Purpose: Osteoarthritis (OA) is the most common joint disease worldwide and is the primary cause of disability and chronic pain in older adults.Ferroptosis is a type of programmed cell death characterized by aberrant iron metabolism and reactive oxygen species accumulation; however, its role in OA is not known. Methods: To identify ferroptosis markers co-expressed in articular cartilage and synovium samples from patients with OA, in silico analysis was performed.Signature genes were analyzed and the results were evaluated using a ROC curve prediction model.The biological function, correlation between Signature genes, immune cell infiltration, and ceRNA network analyses were performed. Signature genes and ferroptosis phenotypes were verified through in vivo animal experiments and clinical samples. The expression levels of non-coding RNAs in samples from patients with OA were determined using qRT-PCR. ceRNA network analysis results were confirmed using dual-luciferase assays. Results: JUN, ATF3, and CDKN1A were identified as OA- and ferroptosis-associated signature genes. GSEA analysis demonstrated an enrichment of these genes in immune and inflammatory responses, and amino acid metabolism. The CIBERSORT algorithm showed a negative correlation between T cells and these signature genes in the cartilage, and a positive correlation in the synovium. Moreover, RP5-894D12.5 and FAM95B1 regulated the expression of JUN, ATF3, and CDKN1A by competitively binding to miR-1972, miR-665, and miR-181a-2-3p. In vivo, GPX4 was downregulated in both OA cartilage and synovium; however, GPX4 and GSH were downregulated, while ferrous ions were upregulated in patient OA cartilage and synovium samples, indicating that ferroptosis was involved in the pathogenesis of OA. Furthermore, JUN, ATF3, and CDKN1A expression was downregulated in both mouse and human OA synovial and cartilage tissues. qRT-PCR demonstrated that miR-1972, RP5-894D12.5, and FAM95B1 were differentially expressed in OA tissues. Targeted interactions between miR-1972 and JUN, and a ceRNA regulatory mechanism between RP5-894D12.5, miR-1972, and JUN were confirmed by dual-luciferase assays. Conclusion: This study identified JUN, ATF3, and CDKN1A as possible diagnostic biomarkers and therapeutic targets for joint synovitis and OA. Furthermore, our finding indicated that RP5-894D12.5/miR-1972/JUN was a potential ceRNA regulatory axis in OA, providing an insight into the connection between ferroptosis and OA. Keywords: osteoarthritis, ferroptosis, synovitis, bioinformatics, JUN, ATF3, CDKN1A, GPX4 Osteoarthritis (OA) is a degenerative joint disease that primarily affects elderly individuals and causes articular cartilage morphology changes, destroys cartilage, and leads to osteophyte formation. 1 It has a high incidence and disability rate and is characterized by joint pain, swelling, and stiffness; thus, it exerts a great burden on both individuals and society. By 2021, OA was estimated to affect approximately 300 million people worldwide, 2 and it ranked sixth in Asia and eleventh globally in terms of years of disability. 3 Early diagnosis and treatment of OA can effectively improve patients' quality of life, delay progression, and reduce the financial burden on patients' families and national healthcare systems. OA is a complex disease caused by multiple factors, including aging, obesity, sex, overuse, trauma, joint deformity, and genetic susceptibility. 4,5 The release of proinflammatory cytokines plays a critical role in synovial inflammation and cartilage matrix destruction, which lead to degradation and destructive responses in articular cartilage, thus contributing to the progression of OA. 6 In 2012, Dix -Abstract Truncated-

SCD1 deficiency exacerbates osteoarthritis by inducing ferroptosis in chondrocytes

Inhibition of Sterol Regulatory Element-Binding Protein-2 Alleviates High-Fat Diet-Induced Deterioration of Knee Cartilage: an Osteoarthritis Animal Model Study

SCP2 Mediates the Transport of Lipid Hydroperoxides to Mitochondria in Chondrocyte Ferroptosis

Chondrocyte ferroptosis contribute to the progression of osteoarthritis

Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression

Single cell RNA-seq analysis identifies ferroptotic chondrocyte cluster and reveals TRPV1 as an anti-ferroptotic target in osteoarthritis

SOST Deficiency Aggravates Osteoarthritis in Mice by Promoting Sclerosis of Subchondral Bone

OGT promotes the ferroptosis of chondrocytes in osteoarthritis development via O-GlcNAcylation modification of ACSF2

Exosomes from osteoarthritic fibroblast-like synoviocytes promote cartilage ferroptosis and damage via delivering microRNA-19b-3p to target SLC7A11 in osteoarthritis

Epigenetic mechanisms of Nsd1-mediated histone methylation modifications in chondrocyte ferroptosis in knee osteoarthritis

The RNA-binding protein SND1 promotes the degradation of GPX4 by destabilizing the HSPA5 mRNA and suppressing HSPA5 expression, promoting ferroptosis in osteoarthritis chondrocytes

Chsy1 deficiency reduces extracellular matrix productions and aggravates cartilage injury in osteoarthritis

Selenophosphate synthetase 1 deficiency exacerbates osteoarthritis by dysregulating redox homeostasis

Bioinformatics and Integrative Experimental Method to Identifying and Validating Co-Expressed Ferroptosis-Related Genes in OA Articular Cartilage and Synovium

Sirt1 Protects Cartilage Against Degradation Through FoxO1 Nucleo-cytoplasmic Shuttling and Positive Regulation of Autophagy

Inhibition of SAT1 alleviates chondrocyte inflammation and ferroptosis by repressing ALOX15 expression and activating the Nrf2 pathway

Pyruvate Dehydrogenase Kinase 1 inhibition mediated oxidative phosphorylation enhancement in cartilage promotes osteoarthritis progression

DSCR1-1 attenuates osteoarthritis-associated chondrocyte injury by regulating the CREB1/ALDH2/Wnt/β-catenin axis: An in vitro and in vivo study

Hepatic stearoyl-CoA desaturase-1 deficiency induces fibrosis and hepatocellular carcinoma-related gene activation under a high carbohydrate low fat diet

Mechanical overloading induces GPX4-regulated chondrocyte ferroptosis in osteoarthritis via Piezo1 channel facilitated calcium influx

Characteristics and Time Points to Inhibit Ferroptosis in Human Osteoarthritis